Related Experiment Video
Updated: Jul 4, 2025

06:46
Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
270
Should Recommendations for Cancer Screening Differentiate on Race?
H Gilbert Welch1, Adewole S Adamson2
1Center for Surgery and Public Health, Brigham and Women's Hospital, Boston.
NEJM Evidence
|February 6, 2024
Summary
Cancer screening guidelines often vary by age, sex, and risk factors. The question remains whether race should also be a factor in cancer screening recommendations.
Area of Science:
- Oncology
- Public Health
- Genetics
Background:
- Current cancer screening guidelines utilize age, sex, and high-risk behaviors to determine eligibility.
- These guidelines aim to balance early detection with the risk of overdiagnosis and other health issues.
- Factors like sex and behavior are already incorporated, prompting a discussion on other demographic variables.
Discussion:
- The abstract questions the exclusion of race as a factor in cancer screening recommendations.
- It highlights that age, sex, and behavioral risk factors are already used to personalize screening.
- This raises the need to explore if race-based risk stratification is scientifically justifiable and ethically sound.
Key Insights:
- Cancer screening protocols are not uniform and are adapted based on individual risk profiles.
- Existing guidelines consider age, sex, and lifestyle factors.
- The ethical and scientific basis for including or excluding race in these recommendations is under review.
Outlook:
- Further research is needed to determine if race-based cancer screening offers significant benefits.
- Future guidelines may need to address racial disparities in cancer outcomes.
- Personalized cancer screening strategies could evolve to incorporate a broader range of demographic and genetic factors.
Related Concept Videos
Cancer Survival Analysis
348
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
348
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Skin Cancer
4.1K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.1K

